# Last Session Summary — 2026-06-30 (autonomous continuation, session 5)

## 1. What was accomplished

**Checklist P4–P5 code implementation and sign-off:**

Four new code changes landed this session, completing the scientific review fix plan through P5:

| Change | File | Purpose |
|--------|------|---------|
| `technology` param + UserWarning | `src/scvi/external/cytovi/_preprocessing.py` | Guard cofactor=5 (CyTOF default) on flow/spectral-flow data (P4-E) |
| `BNHL_CONTINUAL_SPLIT` + `_split_by_entity()` | `benchmarks/cytoanvi/data.py` | Biological entity split for B4/B6 (P5-B); entity_key="Entity" (capital E) |
| `get_uncertainty_threshold()` + export | `src/cytoanvi/_uncertainty.py`, `__init__.py` | Specificity-calibrated novelty threshold API (P5-C) |
| `precision_at_specificity()` | `benchmarks/cytoanvi/metrics.py` | Novelty-detection precision at target specificity (P5-C) |

**Checklist fully updated:** `.scratch/cytoanvi-scientific-review-fixes.md` — all P0–P5 items marked `[x]` / `[~]` / `[-]` with evidence. P4-D, P4-E, P5-A through P5-D marked done; P4-A/B/C and P5-E carry blockers.

**New learning:** L-023 — `transform_arcsinh` lives in `cytovi/_preprocessing.py`, not `benchmarks/common/preprocessing.py`.

## 2. Cumulative benchmark status

| Task | Status | Result |
|------|--------|--------|
| B1 Roider | ✓ pub-grade | Δ+0.121±0.040 |
| B1 Nuñez inductive | RUNNING (PID 1520357, seed 0; ETA all-3-seeds ~06:00 Jul 1) | leakage fix (L-022) |
| B2 | ✓ | bio +0.108, batch Δ−0.006 |
| B3 | ✓ | concordance 0.877±0.012 |
| B4 | Blocked (pseudo split) | plumbing only |
| B5 | ✓ multiseed | best 0.833±0.122, mean 0.462±0.075 |
| B6 | Blocked | plumbing only |
| B8 | ✅ pub-gate | Δ_hier +0.0862±0.0027 |
| B9 | Blocked (mapqc) | — |

## 3. P4–P5 fix status summary

| Item | Status | Evidence |
|------|--------|---------|
| P4-A | [~] | PID 1520357 running; `annotate_inductive_knn()` confirmed in annotate_nunez.py |
| P4-B | [-] | Blocked on v2 .h5ad file from P4-A GPU run |
| P4-C | [-] | Blocked on user Figshare credentials |
| P4-D | [x] | `ARCSINH_COFACTORS = {"nunez": 5, ...}` in benchmarks/common/preprocessing.py ✓ |
| P4-E | [x] | `technology` param + UserWarning in cytovi/_preprocessing.py |
| P5-A | [x] | flowsom_knn, phenograph_knn, xgboost in baselines.py ✓ |
| P5-B | [x] | `BNHL_CONTINUAL_SPLIT` + `_split_by_entity()` in data.py |
| P5-C | [x] | `get_uncertainty_threshold()` in _uncertainty.py; `precision_at_specificity()` in metrics.py |
| P5-D | [x] | collapse_cd45_markers() `.. warning::` docstring present ✓ |
| P5-E | [-] | Deferred; requires user env decision |

## 4. Publication risks — current state

### Critical
1. **Nuñez annotation transductive leakage** — in progress via PID 1520357 (leakage fix L-022; inductive kNN)
2. **B1 Nuñez inductive result pending** — reversal (CytoANVI < kNN in vignette) may narrow or resolve
3. Archive `nunez_annotated.h5ad` to Figshare + auto-download (P4-C, user action)

### High
- B4/B6: Real rLN vs FL/MCL biological split (`_split_by_entity` now available) OR demote to supplement
- B9: Install `mapqc` in conda env (user action, unblocks B9)
- P5-E: conda lock + REPRODUCE.md (user decision on env spec)

## 5. Open items for next session

**Immediate (B1 inductive, ETA ~06:00 Jul 1):**
- Read `results/e1000/nunez_inductive_b1_multiseed.json` when it appears
- Determine if reversal (CytoANVI < kNN) persists or narrows after leakage fix
- Update F-003 in FINDINGS_REGISTRY and label-transfer-accuracy.md
- Update ANALYSIS_MANIFEST B1 row

**Blocked on user:**
- `scancel 25089685 25102610` (2 stale DependencyNeverSatisfied SLURM jobs)
- Install `mapqc` in conda env (unblocks B9)
- B4: real rLN vs FL/MCL biological entity split (API now in data.py) OR demote to supplement
- P5-E: conda lock / REPRODUCE.md / Singularity.def decision

**Next code work:**
- After B1 inductive completes: commit updated findings to FINDINGS_REGISTRY + ANALYSIS_MANIFEST
- Commit all this session's code changes (P4-E, P5-B, P5-C) to `feat/cytoanvi`
- Consider pushing `feat/cytoanvi` branch for upstream PR
